Market
What will be PureHealth's next major acquisition by end of 2025?
2
Resolution / Starting Odds
Another Greek healthcare entity • 25%
Healthcare entity outside Greece • 25%
No major acquisition • 25%
Other • 25%
Official announcements from PureHealth, financial news outlets
Story
PureHealth Acquires 60% Stake in Hellenic Healthcare Group from CVC Capital for $2.3 Billion
Jan 27, 2025, 02:38 PM
Abu Dhabi-based PureHealth is acquiring a 60% stake in Hellenic Healthcare Group from CVC Capital Partners, marking a significant move in the healthcare sector. The deal is valued at approximately $2.3 billion, reflecting the growing interest of foreign investment in Greece's healthcare landscape. CVC Capital, which has been a dominant player in Greece's private hospital sector, is reportedly selling the majority stake as part of its strategy to capitalize on the increased valuation of its investments. This acquisition aligns with PureHealth's expansion strategy in the healthcare market.
View original story
Similar markets
Technology company • 25%
Healthcare provider • 25%
Insurance company • 25%
Other • 25%
Vertex Pharmaceuticals • 25%
Other Biopharma Companies • 25%
Biogen • 25%
Gilead Sciences • 25%
Gilead Sciences • 25%
Other • 25%
AstraZeneca • 25%
Biogen • 25%
Other • 25%
Kaiser Permanente • 25%
Cleveland Clinic • 25%
Mayo Clinic • 25%
No • 50%
Yes • 50%
Other • 25%
Pfizer • 25%
GSK • 25%
Eli Lilly • 25%
Eli Lilly • 25%
Johnson & Johnson • 25%
Other • 25%
GSK • 25%
General Catalyst • 25%
A new investor • 25%
Kleiner Perkins • 25%
Other existing investor • 25%
Sage Therapeutics • 25%
A company with a marketed drug • 25%
A company with mid-stage drug development • 25%
A company with late-stage drug development • 25%
Another named biotech company • 25%
No further acquisitions • 25%
Multiple companies • 25%
Stoke Therapeutics • 25%